MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Xenomics, Inc. (Pink Sheets: XNOM), a developer of non-invasive next-generation molecular diagnostics, announced today the re-structuring of its 6% Convertible Debentures (the “Debentures”) issued in November 2006.
